XML 73 R55.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF CONDENSED INCOME STATEMENT (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenues, net $ 199,614,000 $ 130,193,000
Loss from operations 8,822,000 431,000
Net loss (17,481,000) (24,411,000)
Melt Pharmaceuticals, Inc. [Member]    
Revenues, net
Loss from operations (13,687,000) (7,581,000)
Net loss $ (13,238,000) $ (11,271,000)